Table 2 Prevalence, attack rate, and distribution by sex and age of patients positive for DENV, CHIKV, and ZIKV

Male % (N)

27.3 (9)

40.4 (19)

13.8 (4)

n/a

Female % (N)

72.7 (24)

59.6 (28)

86.2 (25)

n/a

Age, Years (Mean ± SEM)

21.1 ± 2.0

21.1 ± 2.3

29.7 ± 2.1*

0.006^a*

 0–10

24.2 (8)

38.3 (18)

0 (0)

0.200^b

 11–20

24.2 (8)

14.9 (7)

20.7 (6)

0.366^a

 21–30

33.3 (11)

19.1 (9)

37.9 (11)

0.666^a

 31–40

12.1 (4)

10.6 (5)

24.1 (7)

0.838^a

 41–50

3.0 (1)

10.6 (5)

6.9 (2)

0.505^c

 Older than 50

3.0 (1)

6.4 (3)

10.3 (3)

0.337^c

 Prevalence % (95% CI)

21.0 (14.6–27.4)

29.9 (22.8–37.1%)

18.5 (12.4–24.5)

0.462 ^d

 Attack rate × 100,000 Inhabitants

40.9 × 10⁵

58.4 × 10⁵

36.0 × 10⁵

n/a